Recent advances in the medical management of breast cancer: highlights from the 29th San Antonio Breast Cancer Conference San Antonio, TX, USA, 14-17 December 2007.
The 29th edition of the San Antonio Breast Cancer Symposium was attended by a total of > 8000 basic scientists, translational researchers, clinical investigators and physicians gathering from approximately 80 countries worldwide. This is the largest meeting focusing on breast cancer, encompassing a wide array of topics from prevention, aetiology and diagnosis to molecular biology and treatment. From the main presentations at the meeting, it seems clear that combined efforts at prevention and treatment of this disease have translated into small, but significant, achievements. Much of the research in the area is focused on improving the therapeutic ratio of available treatments by better selection of patients.
Montemurro
Filippo
F
Division of Oncology and Haematology, Institute for Cancer Research and Treatment (IRCC), Strada Provinciale 142, Km 3.9510060 Candiolo, Italy. filippo.montemurro@ircc.it
Redana
Stefania
S
Valabrega
Giorgio
G
Aglietta
Massimo
M
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000517:prevention & control; D017024:Chemotherapy, Adjuvant; D004334:Drug Administration Schedule; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D008019:Life Style; D009362:Neoplasm Metastasis / Q000188:drug therapy; D018579:Patient Selection; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000187:drug effects / Q000276:immunology; D012307:Risk Factors
D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D018719:Erb-b2 Receptor Tyrosine Kinases